Home / Inspections / 1182096

FDA Inspection 1182096 — Boehringer Ingelheim RCV GmbH & Co KG

Boehringer Ingelheim RCV GmbH & Co KG — FEI 3003433722

The FDA completed an inspection of Boehringer Ingelheim RCV GmbH & Co KG on September 16, 2022 in Vienna. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 16, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Vienna (Austria)

Facility

Other inspections at this facility

  • 1327044 (VAI Fri Jul 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1258048 (NAI Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1210971 (NAI Thu Mar 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1170761 (VAI Thu Jan 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 905984 (VAI Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources